Table 1.

Baseline characteristics by DLBCL subtype

Characteristics	ABC (N = 38)	GCB (N = 20)	Unclassified (N = 17)	Unknown (N = 5)
Median age, years (range)	60 (34–89)	65 (28–92)	63 (44–85)	65 (58–78)
Sex (male)	66%	70%	82%	60%
ECOG performance score ≥ 2	5%	20%	24%	40%
RIPI (poor)	63%	59%	50%	60%
Median time from diagnosis, months (range)	19 (4–118)	17 (11–104)	21 (7–332)	19 (9–57)
Median number of prior regimens (range)	3 (1–7)	3.5 (1–7)	3 (1–4)	3 (1–3)
Prior ASCT	13%	30%	24%	40%
Chemotherapy-refractory disease	66%	65%	59%	50%

ABC, activated B cell–like; ASCT, autologous stem cell transplant; DLBCL, diffuse large B cell lymphoma; ECOG, Eastern Cooperative Oncology Group; GCB, germinal center B cell–like; RIPI, revised international prognostic index.